Surging global oncology pipeline investments, expanding FDA and EMA approvals for genetically modified cell therapies, and continuous biopharmaceutical refinements in targeted vector delivery platforms are driving rapid growth across the global Cancer Gene Therapy Market. Cancer gene therapies—comprising chimeric antigen receptor (CAR)-T cell therapies, oncolytic virus regimens,...
